Literature DB >> 19896716

Human astrovirus coat protein binds C1q and MBL and inhibits the classical and lectin pathways of complement activation.

Pamela S Hair1, Jenny Q Gronemus, Katrina B Crawford, Veena P Salvi, Kenji M Cunnion, Nicole M Thielens, Gérard J Arlaud, Nenoo Rawal, Neel K Krishna.   

Abstract

Human astroviruses (HAstVs) constitute a family of non-enveloped, RNA viruses which cause infantile gastroenteritis. We have previously demonstrated that purified HAstV coat protein (CP), multiple copies of which compose the viral capsid, bind C1q resulting in inhibition of classical complement pathway activity. The objective of this study was to further analyze the mechanism by which CP inhibits C1 activation. CP inhibited C1 activation, preventing cleavage of C1s to its active form in the presence of heat-aggregated IgG, a potent classical pathway activator. CP also inhibited generation of the potent anaphylatoxin C5a. CP dose-dependently bound to C1q, the isolated globular heads and the collagen-like regions of the C1q molecule. When CP was added to C1, C1s dissociated from C1q suggesting that CP functionally displaces the protease tetramer (C1s-C1r-C1r-C1s). Given the structural and functional relatedness of C1q and MBL, we subsequently investigated the interactions between CP and MBL. CP bound to purified MBL and was able to inhibit mannan-mediated activation of the lectin pathway. Interestingly, CP did not bind to a variant of MBL that replaces a lysine residue (Lys55) critical for binding to MASP-2, a functional homolog of C1s. Finally, CP was shown to cross the species barrier to inhibit C3 activation and MAC formation in rat serum. These findings suggest CP inhibits C1 and MBL activation via a novel mechanism of interference with the normal interaction of the recognition molecule with its cognate serine proteases. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19896716     DOI: 10.1016/j.molimm.2009.10.006

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  29 in total

Review 1.  Viral-derived complement inhibitors: current status and potential role in immunomodulation.

Authors:  Hadi Abou-El-Hassan; Hassan Zaraket
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-26

Review 2.  Interactions of viruses and the humoral innate immune response.

Authors:  Bailey E Maloney; Krishani Dinali Perera; Danielle R D Saunders; Naemi Shadipeni; Sherry D Fleming
Journal:  Clin Immunol       Date:  2020-02-04       Impact factor: 3.969

Review 3.  Human astroviruses.

Authors:  Albert Bosch; Rosa M Pintó; Susana Guix
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

4.  Torque teno virus viremia load size in patients with selected congenital defects of innate immunity.

Authors:  Fabrizio Maggi; Massimo Pifferi; Angela Michelucci; Melania Albani; Selenia Sbranti; Letizia Lanini; Paolo Simi; Pierantonio Macchia; Mauro Pistello; Mauro Bendinelli
Journal:  Clin Vaccine Immunol       Date:  2011-02-16

5.  A novel peptide inhibitor of classical and lectin complement activation including ABO incompatibility.

Authors:  Clifford T Mauriello; Haree K Pallera; Julia A Sharp; Jon L Woltmann; Shizhi Qian; Pamela S Hair; Pieter van der Pol; Cees van Kooten; Nicole M Thielens; Frank A Lattanzio; Kenji M Cunnion; Neel K Krishna
Journal:  Mol Immunol       Date:  2012-08-18       Impact factor: 4.407

6.  OASL Triggered by Novel Goose Astrovirus via ORF2 Restricts Its Replication.

Authors:  Dan Ren; Tuofan Li; Xinyu Zhang; Xiaohui Yao; Wei Gao; Quan Xie; Jianjun Zhang; Hongxia Shao; Zhimin Wan; Aijian Qin; Jianqiang Ye
Journal:  J Virol       Date:  2020-11-23       Impact factor: 5.103

7.  C1q binding to dengue virus decreases levels of infection and inflammatory molecules transcription in THP-1 cells.

Authors:  Bruno Douradinha; Sean P McBurney; Klecia M Soares de Melo; Amanda P Smith; Neel K Krishna; Simon M Barratt-Boyes; Jared D Evans; Eduardo J M Nascimento; Ernesto T A Marques
Journal:  Virus Res       Date:  2013-11-15       Impact factor: 3.303

Review 8.  Complement and viral pathogenesis.

Authors:  Kristina A Stoermer; Thomas E Morrison
Journal:  Virology       Date:  2011-02-02       Impact factor: 3.616

9.  Peptide Inhibitor of Complement C1 (PIC1) Rapidly Inhibits Complement Activation after Intravascular Injection in Rats.

Authors:  Julia A Sharp; Pamela S Hair; Haree K Pallera; Parvathi S Kumar; Clifford T Mauriello; Julius O Nyalwidhe; Cody A Phelps; Dalnam Park; Nicole M Thielens; Stephen M Pascal; Waldon Chen; Diane M Duffy; Frank A Lattanzio; Kenji M Cunnion; Neel K Krishna
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

Review 10.  Novel Evasion Mechanisms of the Classical Complement Pathway.

Authors:  Brandon L Garcia; Seline A Zwarthoff; Suzan H M Rooijakkers; Brian V Geisbrecht
Journal:  J Immunol       Date:  2016-09-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.